Last reviewed · How we verify

Placebo matched to Rifampin

Hamilton Health Sciences Corporation · Phase 3 active Small molecule

Placebo matched to Rifampin is a Bacterial RNA polymerase inhibitor Small molecule drug developed by Hamilton Health Sciences Corporation. It is currently in Phase 3 development for Treatment of tuberculosis, Prophylaxis of meningococcal meningitis.

Rifampin is a bacterial RNA polymerase inhibitor.

Rifampin is a bacterial RNA polymerase inhibitor. Used for Treatment of tuberculosis, Prophylaxis of meningococcal meningitis.

At a glance

Generic namePlacebo matched to Rifampin
SponsorHamilton Health Sciences Corporation
Drug classBacterial RNA polymerase inhibitor
TargetBacterial RNA polymerase
ModalitySmall molecule
Therapeutic areaInfectious Diseases
PhasePhase 3

Mechanism of action

Rifampin works by binding to the beta subunit of bacterial RNA polymerase, thereby inhibiting RNA synthesis and ultimately leading to the death of the bacterial cell. This results in a decrease in the bacterial load and a reduction in the severity of symptoms associated with bacterial infections.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo matched to Rifampin

What is Placebo matched to Rifampin?

Placebo matched to Rifampin is a Bacterial RNA polymerase inhibitor drug developed by Hamilton Health Sciences Corporation, indicated for Treatment of tuberculosis, Prophylaxis of meningococcal meningitis.

How does Placebo matched to Rifampin work?

Rifampin is a bacterial RNA polymerase inhibitor.

What is Placebo matched to Rifampin used for?

Placebo matched to Rifampin is indicated for Treatment of tuberculosis, Prophylaxis of meningococcal meningitis.

Who makes Placebo matched to Rifampin?

Placebo matched to Rifampin is developed by Hamilton Health Sciences Corporation (see full Hamilton Health Sciences Corporation pipeline at /company/hamilton-health-sciences-corporation).

What drug class is Placebo matched to Rifampin in?

Placebo matched to Rifampin belongs to the Bacterial RNA polymerase inhibitor class. See all Bacterial RNA polymerase inhibitor drugs at /class/bacterial-rna-polymerase-inhibitor.

What development phase is Placebo matched to Rifampin in?

Placebo matched to Rifampin is in Phase 3.

What are the side effects of Placebo matched to Rifampin?

Common side effects of Placebo matched to Rifampin include Hepatotoxicity, Thrombocytopenia, Nausea, Vomiting, Abdominal pain.

What does Placebo matched to Rifampin target?

Placebo matched to Rifampin targets Bacterial RNA polymerase and is a Bacterial RNA polymerase inhibitor.

Related